Risankizumab Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Efficacy and Safety in the Randomized Phase 3 INSPIRE Study.
Unknown authors
Topics & Concepts
Ulcerative colitisMedicineRandomized controlled trialPhase (matter)Internal medicineColitisGastroenterologyDiseasePhysicsQuantum mechanicsInflammatory Bowel DiseaseMicroscopic ColitisCeliac Disease Research and Management